| clopidogrel / Generic mfg. |
2020-004263-84: AntiPlatelet theraPy stratEgy followiNg left atrial appenDAGe closurE Stratégie d'Antiagrégation Plaquettaire Post ExclusioN De l'Auricule GauchE |
|
|
| Not yet recruiting | 2 | 60 | Europe | Film-coated tablet, Powder and solvent for oral solution, Plavix 75mg, Kardegic 160 mg | CHU de Bordeaux, CHU de Bordeaux | Atrial Fibrillation, atrial appendage, anticoagulants, stroke, platelet aggregation inhibitors Fibrillation auriculaire, appendice auriculaire, anticoagulants, accident vasculaire cérébral, inhibiteurs de l'agrégation plaquettaire, Atrial Fibrillation, atrial appendage, anticoagulants, stroke, platelet aggregation inhibitors Fibrillation auriculaire, appendice auriculaire, anticoagulants, accident vasculaire cérébral, inhibiteurs de l'agrégation plaquettaire, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2013-004376-35: A Clinical Trial for the comparison of Ticagrelor and Clopidogrel in Patients with CoronarY Artery Disease. |
|
|
| Ongoing | 2 | 60 | Europe | Tablet, Brilique, Plavix | Hellenic Cardiovascular Research Society, AstraZeneca SA Hellas | Coronary Artery Disease (with an indication for coronary angiography), The narrowing of the coronary arteries (with an indication for coronary angiography), Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2007-002664-10: A Randomised Comparison Between 150 mg/die Clopidogrel Maintenance Dose Versus 75 mg/die in Patients with ST Segment Elevation Acute Myocardial Infarction: Effects on Platelet Aggregation and Inflammatory Markers |
|
|
| Ongoing | 2 | 40 | Europe | PLAVIX*28CPR RIV 75MG, PLAVIX*28CPR RIV 75MG | AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | ST Segment Elevation Acute Myocardial Infarction | | | | |
2007-003218-33: Antitrombotisk effekt af ADP receptor inhibitor i tillæg til Aspirin til hyperkoagulable patienter der gennemgår CABG kirurgi. |
|
|
| Ongoing | 2 | 130 | Europe | Clopidogrel, Clopidogrel, Clopidogrel | Blood bank, Rigshospitalet, University Hospital of Copenhagen | Patients with coronary syndrome undergoing CABG in cardiopulmonary bypass receiving postoperative treatment with aspirin alone | | | | |
2009-011907-22: Antiplatelet treatment in patients with diabetes mellitus: is there a difference between aspirin, clopidogrel and prasugrel |
|
|
| Ongoing | 2 | 56 | Europe | prasugrel hydrochloride, clopidogrel, aspirin, LY640315, Efient, plavix, Efient, plavix | University of Leeds | Type 2 diabetes mellitus | | | | |
2014-003733-25: Pilot Study related to the effect of clopidogrel on plasmatic soluble CD40 ligand during systemic lupus erythematous Essai pilote de phase I/II testant l’effet du clopidogrel sur les taux plasmatiques de CD40 ligand soluble chez des patients affectés de lupus érythémateux systémique |
|
|
| Not yet recruiting | 2 | 30 | Europe | CLOPIDOGREL, Tablet, PLAVIX, clopidogrel, 75mg | CHU de BORDEAUX, Ministère de la Santé | systemic lupus erythematous lupus érythémateux systémique, lupus lupus, Body processes [G] - Immune system processes [G12] | | | | |
2017-001567-20: Assessment of Dual antiplatelet therapy versus Rivaroxaban In atrial Fibrillation patients Treated with left atrial appendage closure: The randomized ADRIFT Study Evaluation de la double antiagrégation plaquettaire versus Rivaroxaban dans les suites de la fermeture d'auricule pour les patients souffrant de fibrillation atriale : Etude randomisée ADRIFT |
|
|
| Not yet recruiting | 2 | 90 | Europe | Xarelto 10mg, Xarelto 15 mg, Kardegic, Plavix 75 mg, Tablet, Powder for oral solution, Xarelto 10mg, Xarelto 15 mg, Kardegic, Plavix 75 mg | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | patients souffrant de fibrillation atriale non valvulaire et ayant subi une fermeture d'auricule gauche, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
ChiCTR1800017178: Based on HRMRI to research the effect of resolving phlegm and activating blood circulation to dredge collaterals on plaque stability and cerebral perfusion in sICAS |
|
|
| Not yet recruiting | 2 | 60 | | Control the risk factors, Aspirin 100mg po qd 180days, clopidogrel 75mg po qd 90days ;Control the risk factors, Aspirin 100mg po qd 180days, clopidogrel 75mg po qd 90days, HTHXTLF po bid 180days | Dongfang Hospital of Beijing University of Chinese Medicine; Dongfang Hospital of Beijing University of Chinese Medicine, Financial scientific and technological funds in Beijing and Self financing of the subject | symptomatic intracranial atherosclerotic stenosis, sICAS | | | | |
2020-005098-29: OPTI-STEMI is a randomized, non-profit, open label, multicentre phase II trial for the evaluation of new therapeutic strategies to reduce microvascular obstruction and to optimize revascularization in non-culprit stenosis in STEMI myocardial infarction. OPTI-STEMI è uno studio randomizzato, no-profit, open label, multicentrico di fase II per la valutazione di nuove strategie terapeutiche per ridurre l’ostruzione microvascolare e per ottimizzare la rivascolarizzazione in stenosi non-culprit nell’infarto miocardico STEMI. |
|
|
| Ongoing | 2 | 520 | Europe | Metoprololo, Atorvastatina, Eparina sodica, Adenosina, Colchicina, Clopidogrel, Ticagrelor, Liraglutide, Prasugrel, Ramipril, Acido acetilsalicilico, Abciximab, [NA], Infusion, Tablet, Solution for injection | DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA - UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II, Ministero dell’Istruzione, dell’Università e della Ricerca Progetto MIUR codice 2017PZY5K7 | Patients with acute ST-elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD) defined by at least one non-culprit stenosis (NCS) with angiographic severity between 30 and 90% Pazienti infarto miocardico acuto con sopraslivellamento del tratto ST (STEMI) e con malattia coronarica multivasale (MVD) definita da almeno una stenosi non culprit (NCS) con severità angiografica tra il 30 ed il 90%, Patients with microvascular obstruction with non-culprit stenosis, i.e. with partial stenosis, between 30% and 90%, of coronary vessels. Pazienti con ostruzione microvascolare con stenosi non-culprit, ossia con stenosi parziale, tra il 30% e il 90%, dei vasi coronarici., Diseases [C] - Cardiovascular Diseases [C14] | | | | |
SYNIVUS-DAPT, NCT03606642: SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy |
|
|
| Active, not recruiting | 2 | 50 | US | Dual Antiplatelet (DAPT) Therapy, Ticagrelor (Brilinta), Clopidogrel (Plavix), Prasugrel (Effient) with Aspirin, The Synergy® stent | HonorHealth Research Institute, Boston Scientific Corporation | Coronary Artery Disease, Atherosclerosis, Stent Placement | 12/21 | 12/23 | | |
2021-005788-34: Platelet inhibition versus direct oral anticoagulation in patients undergoing percutaneous closure of patent foramen ovale or atrial septal defect Plaatjesremming versus directe antistollingsmedicatie bij patiënten die sluiting van een patent foramen ovale of atriaal septum defect ondergaan |
|
|
| Ongoing | 2 | 52 | Europe | Tablet, Plavix, Acetylsalicylylzuur Cardio (and others), Xarelto | St. Antonius Hospital, St. Antonius Onderzoeksfonds | Atrial septal defect or patent foramen ovale indicated for percutaneous closure with an occluder device. Atriaal septum defect of patent foramen ovale met een indicatie om percutaan te sluiten met een implantaat, Atrial septal defect or patent foramen ovale indicated for percutaneous closure with an occluder device. Atriaal septum defect of patent foramen ovale met een indicatie om via de lies (percutaan) te sluiten met een implantaat, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
| Completed | 2 | 33 | US | Endovascular intervention, Aspirin and Clopidogrel (maximal medical Therapy) | Duke University | Cognition Disorder, Stroke, Occlusion Carotid | 03/24 | 03/24 | | |
NCT05567562: Anti-Platelets in Chronic Obstructive Pulmonary Disease |
|
|
| Recruiting | 2 | 30 | US | dual anti-platelet therapy, aspirin 81mg EC tab, clopidogrel 75mg tab, Placebo | Brigham and Women's Hospital, National Heart, Lung, and Blood Institute (NHLBI) | COPD, Emphysema, Emphysema or COPD | 12/24 | 06/25 | | |
| Recruiting | 2 | 200 | Europe | Clopidogrel | St. Antonius Hospital | Acute Coronary Syndrome, CYP2C19 Polymorphism | 06/24 | 01/25 | | |
